Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Triphase Accelerator Initiates Phase I Trial of TRPH-222

contractpharmaApril 02, 2019

Tag: Preclinical , cancer , patients

PharmaSources Customer Service